Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 46 results:
Συντάκτης Τίτλος [ Τύπος![(Asc)](https://www.med.auth.gr/sites/all/modules/biblio/misc/arrow-asc.png)
Φίλτρα: Συντάκτης is Kotoula, Vassiliki [Clear All Filters]
In situ detection of hTERT variants in anaplastic large cell lymphoma..
Leuk Lymphoma. 47(8), 1639-50.
(2006). Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression..
Clin Breast Cancer. 12(3), 183-93.
(2012). Genotyping and Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment..
Cancer Genomics Proteomics. 16(6), 531-541.
(2019). Genotype - phenotype associations in colorectal adenocarcinomas and their matched metastases..
Hum Pathol.
(2020). Genetic mapping of pancreatic cancer by targeted next-generation sequencing e.
ESMO Open. 4(5), e000525.
(2019). Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel..
Anticancer Res. 32(10), 4569-80.
(2012). Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study..
PLoS One. 13(12), e0207707.
(2018).
(2013). Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab..
Cancer Genomics Proteomics. 15(6), 461-471.
(2018). Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin..
Clin Colorectal Cancer. 15(2), 164-9.
(2016). Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis..
J Clin Endocrinol Metab. 91(9), 3662-6.
(2006). DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome..
Pathol Oncol Res. 19(2), 329-43.
(2013). Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumab..
ESMO Open. 4(2), e000441.
(2019). Crizotinib Failure in a TPM4-ALK –Rearranged Inflammatory Myofibroblastic Tumor With an Emerging ALK Kinase Domain Mutation.
JCO Precision Oncology. 1 - 7.
(2017). Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas..
Cancer Genomics Proteomics. 15(5), 421-436.
(2018). Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition..
J Clin Endocrinol Metab. 92(12), 4845-52.
(2007). Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer..
Anticancer Res. 39(4), 2129-2138.
(2019). Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro..
J Clin Endocrinol Metab. 91(10), 4013-21.
(2006). Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab..
Clin Colorectal Cancer. 18(4), e370-e384.
(2019). AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer..
Clin Colorectal Cancer. 17(4), e631-e637.
(2018). Alleviation of myelodysplastic syndrome-associated skin rush after treatment with decitabine..
Eur J Haematol. 81(6), 489-90.
(2008).